Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Stock-based compensation
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results 4:05 PM EDT 8/19/2026 - Comtex MADISON, Wis., Aug. 19, 2026 /PRNewswire via COMTEX News Network/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2026, ended June 30, 2026. Key Highlights -- The Company's transformation plan delivered more than $20 million of cost and margin improvement during fiscal 2026, significantly exceeding the Company's original target of $12 million.
PTC ANNOUNCES THIRD FISCAL QUARTER 2026 RESULTS
Strategic focus on Intelligent Product Lifecycle vision Strong execution in Q3'26 across all key metrics Constant currency ARR growth of 9.1% excluding divested businesses, exceeding the high end of our guidance range Operating and free cash flow growth of 7% and 3%, respectively, both exceeding the high end of our guidance ranges Raising FY'26 guidance for ARR, Revenue and EPS, reaffirming Cash Flow guidance ~$525 million of shares repurchased in Q3'26, bringing FY'26 repurchases above the...
PTC ANNOUNCES SECOND FISCAL QUARTER 2026 RESULTS
Strategic focus on Intelligent Product Lifecycle vision Solid execution in Q2'26 Constant currency ARR growth of 8.5% excluding divested businesses Operating and free cash flow growth of 14% ~$625 million of cash used for repurchases in Q2'26; targeting repurchases of ~$1.225 billion to ~$1.325 billion in FY'26; New $2 billion share repurchase authorization effective for FY'27-FY'28.
Compass, Inc. Reports First Quarter 2026 Results 4:07 PM EDT 5/05/2026 - Comtex NEW YORK, May 5, 2026 /PRNewswire via COMTEX News Network/ -- Actioned Over $250 Million in Net Cost Synergies in Q1 Increases 2026 Actioned Cost Synergy Target from $250 Million to $300 Million Increases 2026 Realized Cost Synergy Target from $100 Million to $200 Million Q1 GAAP Net Income of $22 Million; Adjusted EBITDA of $61 Million Q1 Pro forma GTV +7.3% YoY for Brokerage & +4.6% YoY for Franchise Compass, Inc.
Stockwatch
2026-02-26 16:05 ET - News Release Quarterly Revenue Grew 23.1% YoY and Organic Revenue Grew 11.3% YoY Produced Record Q4 Revenue of $1.70bln and Record Full Year Revenue of $7.0bln Generated a Record $217 Million in Full-Year Operating Cash Flow , /PRNewswire/ -- Compass, Inc., d/b/a Compass International Holdings ("Compass" or "the Company"), (NYSE: COMP) a global real estate services company with a presence in every major U.S. city and approximately 120 countries and territories, announced...
Stockwatch
Strategic focus on Intelligent Product Lifecycle vision Solid execution in Q1'26 Constant currency ARR growth of 8.4%; 9.0% excluding Kepware and ThingWorx Operating and free cash flow growth of 13% Embedding AI across portfolio and building common AI infrastructure to drive customer adoption and value Executing on our $2 billion share repurchase authorization: $200 million of repurchases in Q1'26; expect to use net after-tax proceeds from the Kepware and ThingWorx divestiture for incremental...
Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results 4:05 PM EDT 8/13/2025 - Comtex MADISON, Wis., Aug. 13, 2025 /PRNewswire via COMTEX News Network/ -- Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 Guidance Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2025, ended June 30, 2025.
Compass, Inc. Reports Record First Quarter 2025 Results 11:03 PM EDT 5/08/2025 - Comtex NEW YORK, May 8, 2025 /PRNewswire via COMTEX News Network/ -- Revenue in Q1 Grew 28.7% YoY and Organic Revenue Grew 14.6% YoY Quarterly Market Share Grew 125bps YoY to a Record 6.0%; Organic Share Was Up 82bps Operating Cash Flow Grew 169% YoY to a Record $23.1 Million in Q1 Compass, Inc.
Compass, Inc. Reports Fourth Quarter and Full-Year 2024 Results 4:05 PM EST 2/18/2025 - Comtex NEW YORK, Feb. 18, 2025 /PRNewswire via COMTEX News Network/ -- Revenue in Q4 Grew 25.9% YoY and Organic Revenue Grew 20.9% YoY Quarterly Market Share Grew 65bps YoY to 5.06% and Organic Share Was Up 48bps $122 Million in Full-Year Operating Cash Flow; $150 Million Prior to NAR-related Settlement Compass, Inc.
Compass, Inc. Reports Third Quarter 2024 Results 4:05 PM EDT 10/30/2024 - Comtex NEW YORK, Oct. 30, 2024 /PRNewswire via COMTEX News Network/ -- Adjusted EBITDA Exceeds High-End of Guidance Reiterates Positive Free Cash Flow Guidance for Full Year 2024 Transactions Increased 16.1% and Quarterly Market Share Grew 49 Basis Points YoY to 4.80% Compass, Inc.
Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results 4:05 PM EDT 8/14/2024 - Comtex MADISON, Wis., Aug. 14, 2024 /PRNewswire via COMTEX News Network/ -- 14% Revenue and 8% Orders Growth in Q4; Company issues FY25 Guidance Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2024, ended June 30, 2024.
Viant Technology Announces First Quarter 2024 Financial Results; Board of Directors Authorizes $50 Million Stock Repurchase Program
IRVINE, Calif., April 30, 2024 (BUSINESS WIRE) -- Viant Technology Inc. (Nasdaq: DSP), a leading advertising technology company, today reported financial results for its first quarter ended March 31, 2024. "We had a strong start to the year as the momentum we saw in the second half of 2023 continued through the first quarter," said Tim Vanderhook, Co-Founder and CEO, Viant.
Compass, Inc. Reports Fourth Quarter and Full Year 2023 Results 4:10 PM EST 2/27/2024 - Comtex NEW YORK, Feb. 27, 2024 /PRNewswire via COMTEX News Network/ -- Grows Agent Count and Market Share year-over-year and quarter-over-quarter in Q4 Expects to Be Free Cash Flow Positive for Full Year 2024 Compass, Inc.
Viant Technology Announces Third Quarter 2023 Financial Results
IRVINE, Calif., November 6, 2023 (BUSINESS WIRE) -- Viant Technology Inc. (Nasdaq: DSP), a leading people-based advertising technology company, today reported financial results for its third quarter ended September 30, 2023. "We had a very strong third quarter, outperforming all guided metrics as we continue to gain share with mid-market customers," said Tim Vanderhook, Co-Founder and CEO, Viant.
Innodata Reports Q3’23 Results; Signs New Big Tech
Innodata Reports Third Quarter 2023 Results and Signing New Big Tech for Generative AI Development Revenue Up 20% Year-Over-Year; Accelerating Growth in Q4 and 2024 Anticipated NEW YORK, NY / ACCESSWIRE / November 2, 2023 / INNODATA INC. (NASDAQ:INOD) today reported results for the third quarter ended September 30, 2023. · Revenue for the quarter ended September 30, 2023 was $22.2 million, up 20% year over year.
Accuray Reports Fourth Quarter and Fiscal 2023 Financial Results 4:10 PM EDT 8/09/2023 - Comtex MADISON, Wis., Aug. 9, 2023 /PRNewswire via COMTEX News Network/ -- 8% Q4 revenue growth; Record shipments for FY23; Company issues guidance for FY24 Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2023, ended June 30, 2023.
Viant Technology Announces Second Quarter 2023 Financial Results
|
Sections Return to News Categories ALL NEWS SECTIONS: View all news categories MOST POPULAR SECTIONS: Cattle - Hogs / Livestock News Currencies News Energy News Grain News Index News Interest Futures News Metals Futures News Reports: Crops, CFTC, etc Soft Commodities News Viant Technology Announces Second Quarter 2023 Financial Results IRVINE, Calif., August 7, 2023 (BUSINESS WIRE) -- Viant Technology Inc.
By Stock-based compensation, ------------------------------------------------------------------------------- --------------------------------------------------------------------------------, ----------------------------------------------------- ------------------------------------------------------, Stockholders' Equity
|
futures.tradingcharts.com
Stratus Properties Inc. Reports First-Quarter 2023 Results
Companies Mentioned SymbolLastChange STRS $21.95 0.00% Stratus Properties Inc. Reports First-Quarter 2023 Results Today 8:15 AM ET (Business Wire)Print Stratus Properties Inc. (NASDAQ: STRS), a diversified real estate company with holdings, interests and operations in the Austin, Texas area and other select markets in Texas, today reported first-quarter 2023 results.
DIGITALOCEAN HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) | MarketScreener
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and our audited consolidated financial statements and the related notes and the discussion under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for...
374WATER INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) | MarketScreener
Forward Looking Statements Readers are cautioned that the statements in this Report that are not descriptions of historical facts may be "forward-looking statements" that are subject to risks and uncertainties. This Report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
UNITED HEALTH PRODUCTS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) | MarketScreener
You should read the following discussion and analysis of our financial condition and results of operations together with our condensed financial statements and related notes appearing elsewhere in this quarterly report on Form 10-Q. This discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions.
SYMBOTIC INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) | MarketScreener
(SYM) Delayed Nasdaq - 04:00:00 2023-05-05 pm EDT 27.04 USD +2.00% 04:13p SYMBOTIC INC.
TRUPANION, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) | MarketScreener
(TRUP) Delayed Nasdaq - 04:00:00 2023-05-05 pm EDT 28.88 USD -19.67% 04:06p TRUPANION, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) AQ 12:04p Piper Sandler Adjusts Trupanion's Price Target to $33 From $44, Keeps Neutral Rating MT 10:36a Trupanion Shares Slump After Company's Q1 Loss Widens MT Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Analyst Reco.
QUINSTREET, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) | MarketScreener
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the fiscal year ended June 30, 2022, filed with the Securities and Exchange Commission ("SEC").
PINEAPPLE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) | MarketScreener
Delayed OTC Markets - 02:29:44 2023-05-04 pm EDT 0.0200 USD 0.00% 12:02p PINEAPPLE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) AQ 04/19 Pineapple, Inc. Updates Shareholders on Status of 2022 Regulatory Filings AQ 03/23 PINEAPPLE, INC.
SIMMONS FIRST NATIONAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) | MarketScreener
(SFNC) Real-time Estimate Cboe BZX - 12:04:33 2023-05-05 pm EDT 16.02 USD +2.04% 11:57a SIMMONS FIRST NATIONAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) AQ 06:11a Insider Buy: Simmons First National MT 05/03 Simmons Bank To Host Free Seminar for Homebuyers PR Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Analyst Reco.
ACCOLADE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) | MarketScreener
The following discussion and analysis of our financial condition and results of our operations should be read together with our consolidated financial statements, including the related notes thereto, appearing at the end of this filing. The following discussion contains forward-looking statements. Actual results may differ significantly from those projected in the forward-looking statements.
CRYPTO CO Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-K) | MarketScreener
This report contains forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including, "could" "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential" and the negative of these terms or other comparable terminology. These statements are only predictions.
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) | MarketScreener
Delayed OTC Markets - 09:30:00 2023-04-10 am EDT 2.750 USD +5.77% 06:10a NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) AQ 2022 Nuo Therapeutics, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ 2022 Nuo Therapeutics, Inc.
NANOMIX CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K) | MarketScreener
You should read the following discussion and analysis of our financial condition and plan of operations together with "Selected Financial Data" and our financial statements and the related notes appearing elsewhere in this prospectus. In addition to historical information, this discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those discussed below.
SHARPLINK GAMING LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) | MarketScreener
Delayed Nasdaq - 04:00:00 2023-04-04 pm EDT 0.3971 USD +1.98% 06:06a SHARPLINK GAMING LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) AQ 02/24 SharpLink Gaming Ltd. announced that it has received $4.4 million in funding CI 02/17 SHARPLINK GAMING LTD.
ELVICTOR GROUP, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) | MarketScreener
The following discussion and analysis of the Company's financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and the notes thereto, which are included in "Item 8. Consolidated Financial Statements and Supplementary Data" of this Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements.
OPTIMUS HEALTHCARE SERVICES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-K) | MarketScreener
End-of-day quote OTC Markets - 2023-03-28 1.350 USD 0.00% 10:36a OPTIMUS HEALTHCARE SERVICES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-K) AQ 2022 Optimus Healthcare Services, Inc. : Other Events (form 8-K) AQ 2022 An unknown buyer agreed to acquire AdhereRx Incorporated from Optimus Healthcare Services, Inc. for approximately $3 million.
APPYEA, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) | MarketScreener
The following Management's Discussion and Analysis of Financial Condition and Results of Operations is intended to provide information necessary to understand our audited consolidated financial statements for the fiscal years ended December 31, 2022 and December 31, 2021 and highlight certain other information which, in the opinion of management, will enhance a reader's understanding of our financial condition, changes in financial condition and results of operations.
ARENA GROUP HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) | MarketScreener
(AREN) Delayed Nyse - 15:16:06 31/03/2023 BST 4.235 USD +9.43% 03:16p The Arena Group Prices Equity Offering of About 3 Million Shares at $3.88/Share MT 02:27p Insider Buy: Arena Group Holdings MT 02:17p ARENA GROUP HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) AQ Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Analyst Reco.
CANOO INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) | MarketScreener
(GOEV) Real-time Estimate Cboe BZX - 05:29:39 2023-03-30 pm EDT 0.5780 USD -6.14% 05:02p CANOO INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) AQ 04:43p Canoo inc. announces fourth quarter and fiscal year 2022 financial results PR 06:19a North American Morning Briefing: Stocks Seen -2- DJ Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Analyst Reco.
SURGEPAYS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) | MarketScreener
The following discussion and analysis should be read in conjunction with our consolidated financial statements and related notes appearing elsewhere in this Annual Report. In addition to historical information, this discussion and analysis contains forward-looking statements that involve risks, uncertainties, and assumptions.
MORNINGSTAR, INC. : Regulation FD Disclosure (form 8-K)
Item 7.01. Regulation FD Disclosure. The following information is included in this Current Report on Form 8-K as a result of Morningstar, Inc.'s policy regarding public disclosure of corporate information. Answers to inquiries submitted between March 1, 2023 and March 31, 2023, if any, that comply with this policy are scheduled to become available around April 28, 2023.
ADM ENDEAVORS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-K) | MarketScreener
Forward Looking Statements This Annual Report on Form 10-K contains forward-looking statements within the meaning of Rule 175 of the Securities Act of 1933, as amended, and Rule 3b-6 of the Securities Act of 1934, as amended, that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our industry, our beliefs and our assumptions.
COCRYSTAL PHARMA, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) | MarketScreener
The following discussion and analysis should be read in conjunction with the Consolidated Financial Statements included elsewhere in this report. Company Overview We develop novel medicines for use in the treatment of human viral diseases. Cocrystal has been developing novel technologies and approaches to create first-in-class and best-in-class antiviral drug candidates since 2008.
AVALO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) | MarketScreener
(AVTX) Delayed Nasdaq - 04:00:00 2023-03-28 pm EDT 1.740 USD 0.00% 07:37a AVALO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) AQ 07:35a Avalo Therapeutics, Inc.
BLUEBIRD BIO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) | MarketScreener
(BLUE) Delayed Nasdaq - 04:00:00 2023-03-28 pm EDT 4.320 USD -4.21% 07:08a BLUEBIRD BIO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) AQ 07:05a Bluebird bio Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Operational Progress BU 07:04a Bluebird Bio, Inc.
FOMO WORLDWIDE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) | MarketScreener
References in this Quarterly Report on Form 10-Q to "the Company," "FOMO," "us," "we," "our," and similar terms refer to FOMO Worldwide, Inc. and its subsidiaries.
CELCUITY INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) | MarketScreener
(CELC) Delayed Nasdaq - 04:00:00 2023-03-23 pm EDT 10.06 USD +0.50% 05:19p CELCUITY INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) AQ 03/15 Celcuity Inc. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) AQ 03/13 Celcuity Inc. : Regulation FD Disclosure (form 8-K) AQ Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Analyst Reco.
BUTTERFLY NETWORK, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) | MarketScreener
(BFLY) Delayed Nyse - 04:00:02 2023-03-23 pm EDT 1.940 USD +1.04% 04:43p BUTTERFLY NETWORK, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) AQ 03/17 Butterfly Network, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) AQ 03/10 Butterfly Network, Inc. : Other Events (form 8-K) AQ Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Analyst Reco.
GEOVAX LABS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) | MarketScreener
The following discussion and analysis of our financial condition and results of operations should be read together with "Selected Financial Data" and our consolidated financial statements and the related notes beginning on page F-1. This discussion contains forward-looking statements that involve risks and uncertainties because they are based on current expectations and relate to future events and our future financial performance.
MONGODB, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) | MarketScreener
(MDB) Delayed Nasdaq - 04:00:01 2023-03-17 pm EDT 219.77 USD -0.67% 04:15p MONGODB, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) AQ 03/10 Credit Suisse Cuts MongoDB's PT to $250 From $305, Believes In-Line Performance 'Was Likely Disappointing'; Keeps Outperform Rating MT 03/10 MongoDB, Inc: Capturing Value Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Analyst Reco.
YEXT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) | MarketScreener
(YEXT) Delayed Nyse - 04:00:02 2023-03-17 pm EDT 9.170 USD -3.27% 04:05p YEXT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) AQ 03/14 Yext Joins the MACH Alliance to Support Open, Best-of-Breed Technology Ecosystems BU 03/09 Yext, Inc.
PHARMACYTE BIOTECH, INC. Management's Discussion and Analysis of Financial Conditions and Results of Operations (form 10-Q) | MarketScreener
(PMCB) Delayed Nasdaq - 04:00:00 2023-03-16 pm EDT 2.880 USD +1.05% 04:45p PHARMACYTE BIOTECH, INC. Management's Discussion and Analysis of Financial Conditions and Results of Operations (form 10-Q) AQ 02/02 Pharmacyte Biotech, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) AQ 02/02 PharmaCyte Biotech, Inc. announces an Equity Buyback for $10 million worth of its shares. CI Summary Quotes Charts News Calendar Company Financials Funds Summary Most relevant All News Analyst Reco.
ETON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) | MarketScreener
You should read the following discussion and analysis together with our financial statements and the related notes thereto included in "Item 8. Financial Statements and Supplementary Data" in this Annual Report on Form 10-K. The following discussion contains forward-looking statements that involve risks and uncertainties.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Stock-based
Contact Stock-based, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack